ZA202212301B - Detecting a chromosome conformation as marker for fibrosis, e.g. scleroderma - Google Patents
Detecting a chromosome conformation as marker for fibrosis, e.g. sclerodermaInfo
- Publication number
- ZA202212301B ZA202212301B ZA2022/12301A ZA202212301A ZA202212301B ZA 202212301 B ZA202212301 B ZA 202212301B ZA 2022/12301 A ZA2022/12301 A ZA 2022/12301A ZA 202212301 A ZA202212301 A ZA 202212301A ZA 202212301 B ZA202212301 B ZA 202212301B
- Authority
- ZA
- South Africa
- Prior art keywords
- scleroderma
- fibrosis
- marker
- detecting
- chromosome conformation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2008269.9A GB202008269D0 (en) | 2020-06-02 | 2020-06-02 | Detecting a chromosome marker |
| PCT/GB2021/051356 WO2021245409A1 (en) | 2020-06-02 | 2021-06-02 | Detecting a chromosome conformation as marker for fibrosis, e.g. scleroderma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA202212301B true ZA202212301B (en) | 2023-07-26 |
Family
ID=71526294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2022/12301A ZA202212301B (en) | 2020-06-02 | 2022-11-10 | Detecting a chromosome conformation as marker for fibrosis, e.g. scleroderma |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230193390A1 (enExample) |
| EP (1) | EP4158066A1 (enExample) |
| JP (1) | JP2023528621A (enExample) |
| KR (1) | KR20230019939A (enExample) |
| CN (1) | CN116507740A (enExample) |
| AU (1) | AU2021283746B2 (enExample) |
| CA (1) | CA3178914A1 (enExample) |
| GB (2) | GB202008269D0 (enExample) |
| IL (1) | IL298266A (enExample) |
| TW (1) | TW202210635A (enExample) |
| WO (1) | WO2021245409A1 (enExample) |
| ZA (1) | ZA202212301B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202314402D0 (en) * | 2023-09-20 | 2023-11-01 | Oxford BioDynamics PLC | Chromosome detection assay |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003259877A (ja) * | 2002-03-11 | 2003-09-16 | Sumitomo Pharmaceut Co Ltd | 肝線維症疾患マーカーおよびその利用 |
| US7468249B2 (en) * | 2004-05-05 | 2008-12-23 | Biocept, Inc. | Detection of chromosomal disorders |
| WO2005111241A2 (en) * | 2004-05-07 | 2005-11-24 | Applera Corporation | Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| AU2006264564B2 (en) * | 2005-07-04 | 2012-04-19 | Erasmus University Medical Center | Chromosome conformation capture-on-chip (4c) assay |
| CN108624668B (zh) * | 2013-02-01 | 2022-12-02 | 加利福尼亚大学董事会 | 用于基因组组装及单体型定相的方法 |
| JP2018527016A (ja) * | 2015-06-24 | 2018-09-20 | オックスフォード バイオダイナミックス リミテッド | 染色体相互作用の検出 |
| ES2971286T3 (es) * | 2016-12-01 | 2024-06-04 | Oxford BioDynamics PLC | Aplicación de interacciones cromosómicas epigenéticas en diagnóstico de cáncer |
| CN111511930B (zh) * | 2017-11-03 | 2024-11-22 | 牛津生物动力有限责任公司 | 通过染色体相互作用遗传调节免疫响应 |
| US20230054595A1 (en) * | 2019-12-18 | 2023-02-23 | The Children's Hospital Of Philadelphia | Novel druggable targets for the treatment of inflammatory diseases such as systemic lupus erythematosus (sle) and methods for diagnosis and treatment using the same |
-
2020
- 2020-06-02 GB GBGB2008269.9A patent/GB202008269D0/en not_active Ceased
-
2021
- 2021-05-31 TW TW110119717A patent/TW202210635A/zh unknown
- 2021-06-02 CN CN202180060427.9A patent/CN116507740A/zh active Pending
- 2021-06-02 IL IL298266A patent/IL298266A/en unknown
- 2021-06-02 WO PCT/GB2021/051356 patent/WO2021245409A1/en not_active Ceased
- 2021-06-02 GB GB2219352.8A patent/GB2611903B/en active Active
- 2021-06-02 US US18/000,243 patent/US20230193390A1/en active Pending
- 2021-06-02 AU AU2021283746A patent/AU2021283746B2/en active Active
- 2021-06-02 JP JP2022574303A patent/JP2023528621A/ja active Pending
- 2021-06-02 EP EP21737122.8A patent/EP4158066A1/en not_active Withdrawn
- 2021-06-02 CA CA3178914A patent/CA3178914A1/en active Pending
- 2021-06-02 KR KR1020237000132A patent/KR20230019939A/ko active Pending
-
2022
- 2022-11-10 ZA ZA2022/12301A patent/ZA202212301B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB202219352D0 (en) | 2023-02-01 |
| AU2021283746B2 (en) | 2023-06-15 |
| WO2021245409A1 (en) | 2021-12-09 |
| GB202008269D0 (en) | 2020-07-15 |
| US20230193390A1 (en) | 2023-06-22 |
| CA3178914A1 (en) | 2021-12-09 |
| CN116507740A (zh) | 2023-07-28 |
| GB2611903B (en) | 2025-08-06 |
| TW202210635A (zh) | 2022-03-16 |
| AU2021283746A1 (en) | 2022-12-22 |
| EP4158066A1 (en) | 2023-04-05 |
| IL298266A (en) | 2023-01-01 |
| GB2611903A (en) | 2023-04-19 |
| JP2023528621A (ja) | 2023-07-05 |
| KR20230019939A (ko) | 2023-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288236A (en) | 3,2-dihydroquinazoline compounds as inhibitors of nav1.8 | |
| GB2603064B (en) | Improved machine learning for technical systems | |
| ZA202004537B (en) | Method for fabricating low-cost, short-production-cycle wear-resistant steel | |
| GB2585951B (en) | System for working machine | |
| ZA202007737B (en) | Pentacyclic compound | |
| EP3926106A4 (en) | CONSTRUCTION MACHINE | |
| EP3904610A4 (en) | CONSTRUCTION MACHINE | |
| EP3667672A4 (en) | GENE REARRANGEMENT DETECTION PROCESS BY NEW GENERATION SEQUENCING | |
| GB2611903B (en) | Detecting a chromosome conformation as marker for fibrosis, e.g. scleroderma | |
| PL2742141T3 (pl) | Wytworzona w bakteriach mikrocyna s, nowy przeciwdrobnoustrojowy peptyd, skuteczny wobec patogennych mikroorganizmów, np. enterokrwotocznej escherichia coli (ehec) | |
| GB202011695D0 (en) | Parcel distributor, especially for stores | |
| WO2011134724A3 (en) | Method for preparing ritodrine hydrochloride | |
| LT3701778T (lt) | Darbo įrankis, ypač dirvožemio įdirbimo įrankis | |
| EP3933058A4 (en) | Tungsten recovery method | |
| HK40092725A (en) | Detecting a chromosome conformation as marker for fibrosis, e.g. scleroderma | |
| EP4020484A4 (en) | METHOD OF DETECTING CHROMOSOMAL ABNORMALITIES BY USING INFORMATION ON THE DISTANCE BETWEEN NUCLEIC ACID FRAGMENTS | |
| EP4015712A4 (en) | CONSTRUCTION MACHINE | |
| EP3941298A4 (en) | ATTACHMENT DEVICE FOR DETACHABLE ATTACHMENT OF AN OBJECT, AND METHOD FOR DETACHABLE ATTACHMENT OF AN OBJECT | |
| IL289141A (en) | Compounds 7,8 dihydro-4h-pyrazolo[3,4-c]azepin-6-one | |
| EP4051791A4 (en) | METHOD FOR DETECTING OLIGONUCLEOTIDES | |
| PL4301874T3 (pl) | Markery interakcji chromosomowej | |
| IL281601A (en) | A method for purifying bio-3,1-butanediol from fermentation liquid | |
| EP3779850A4 (en) | Monitoring system for work machine | |
| WO2009108722A3 (en) | Substituted benzoxazinones | |
| HK40069890A (en) | 2,3-dihydroquinazolin compounds as nav1.8 inhibitors |